BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33599842)

  • 21. Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.
    Vengalil S; Giuliani ME; Huang SH; McNiven A; Song Y; Xu W; Chan B; Hope A; Cho J; Bayley A; Ringash J; Goldstein D; Razak A; Irish J; Gilbert R; Gullane P; Waldron J; Kim J; O'Sullivan B
    Head Neck; 2016 Apr; 38 Suppl 1():E2035-40. PubMed ID: 26828197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
    Janoray G; Pointreau Y; Alfonsi M; Sire C; Geoffrois L; de Raucourt D; Bardet E; Calais MH; Garaud P; Calais G
    Eur J Cancer; 2020 Jul; 133():86-93. PubMed ID: 32454417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
    Tasoulas J; Lenze NR; Farquhar D; P Schrank T; Shen C; Shazib MA; Singer B; Patel S; Grilley Olson JE; Hayes DN; Gulley ML; Chera BS; Hackman T; Olshan AF; Weiss J; Sheth S
    Cancer Med; 2021 May; 10(10):3231-3239. PubMed ID: 33934525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Positive Initial Margins With Survival Among Patients With Squamous Cell Carcinoma Treated With Total Laryngectomy.
    Tassone P; Savard C; Topf MC; Keane W; Luginbuhl A; Curry J; Cognetti D
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1030-1036. PubMed ID: 30054637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
    Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
    Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transoral laser microsurgery as primary treatment for selected T3 glottic and supraglottic cancers.
    Peretti G; Piazza C; Penco S; Santori G; Del Bon F; Garofolo S; Paderno A; Guastini L; Nicolai P
    Head Neck; 2016 Jul; 38(7):1107-12. PubMed ID: 26970262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Selection for T3/T4a Laryngeal Cancer: Chemoradiation Versus Primary Surgery.
    Timme DW; Jonnalagadda S; Patel R; Rao K; Robbins KT
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):845-51. PubMed ID: 25991835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.
    Canis M; Martin A; Ihler F; Wolff HA; Kron M; Matthias C; Steiner W
    Head Neck; 2014 Jun; 36(6):859-66. PubMed ID: 23720321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term functional outcome after laryngeal cancer treatment.
    Anschuetz L; Shelan M; Dematté M; Schubert AD; Giger R; Elicin O
    Radiat Oncol; 2019 Jun; 14(1):101. PubMed ID: 31186027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits and drawbacks of open partial horizontal laryngectomies, Part A: Early- to intermediate-stage glottic carcinoma.
    Succo G; Crosetti E; Bertolin A; Lucioni M; Caracciolo A; Panetta V; Sprio AE; Berta GN; Rizzotto G
    Head Neck; 2016 Apr; 38 Suppl 1():E333-40. PubMed ID: 25581514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Re-evaluation of 191 larynx cancer surgeries according to the Open Partial Horizontal Laryngectomies classification proposed by European Laryngological Society working committee in 2014].
    Wierzbicka M; Leszczyńska M; Szyfter W
    Otolaryngol Pol; 2014; 68(6):281-6. PubMed ID: 25152380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II study.
    Nakata Y; Ijichi K; Hanai N; Nishikawa D; Suzuki H; Hirakawa H; Kodaira T; Fujimoto Y; Fujii T; Miyazaki T; Shimizu T; Hasegawa Y
    Auris Nasus Larynx; 2017 Feb; 44(1):104-110. PubMed ID: 27435048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort Analysis.
    Heukelom J; Navran A; Gouw ZAR; Tesselaar ME; Zuur CL; van Werkhoven E; Sonke JJ; Rasch CRN; Al-Mamgani A
    Otolaryngol Head Neck Surg; 2019 Aug; 161(2):288-296. PubMed ID: 31060436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic indicators and survival in salvage surgery for laryngeal cancer.
    Fletcher KT; Gal TJ; Ebelhar AJ; Valentino J; Brill YM; Dressler EV; Aouad RK
    Head Neck; 2017 Oct; 39(10):2021-2026. PubMed ID: 28681422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncologic outcomes of surgical treatment for T3 glottic laryngeal squamous cell carcinoma.
    Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
    Head Neck; 2018 Aug; 40(8):1734-1742. PubMed ID: 29601122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologic Outcomes After Salvage Laryngectomy for Squamous Cell Carcinoma of the Larynx and Hypopharynx: A Multicenter Retrospective Cohort Study.
    Meulemans J; Debacker J; Demarsin H; Vanclooster C; Neyt P; Mennes T; Vauterin T; Huvenne W; Laenen A; Delaere P; Vander Poorten V
    Ann Surg Oncol; 2021 Mar; 28(3):1751-1761. PubMed ID: 32860174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: Risk Factors for Recurrence and Impact of Adjuvant Treatment.
    Trosman SJ; Zhu A; Nicolli EA; Leibowitz JM; Sargi ZB
    Laryngoscope; 2021 Jan; 131(1):E136-E143. PubMed ID: 32065413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraglottic Space Invasion in Glottic Laryngeal Cancer: A Clinical-Pathological Study.
    Fermi M; Lo Manto A; Di Massa G; Gallo G; Lupi M; Maiolo V; Montrone G; Lovato L; Presutti L; Mattioli F
    Laryngoscope; 2023 May; 133(5):1184-1190. PubMed ID: 37042776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.